For the safety of our patients and staff, we have updated our visitor policy, effective December 27. This includes important information about COVID-19 vaccination or testing for some visitors. Read the latest information for visitors.
Christopher Hulton, PhD
Research Scientist at C4 Therapeutic, Watertown, Massachusetts
Hulton, C.H., Costa, E.A., Shah, N.S. et al. Direct genome editing of patient-derived xenografts using CRISPR-Cas9 enables rapid in vivo functional genomics. (2020) Nat Cancer 1, 359–369 (2020). doi.org/10.1038/s43018-020-0040-8